Hot penny stocks! Don't get burned!
Research Report
Hotstocked.com has a complete research report available for JAV stock. Download JAV report.
Research Report
Get the full report for FREE
Date:Aug 13, 2009
Price:Free
Pages:4
Document Type:Adobe Acrobat Reader
 Download JAV report
  
Example preview: Research report for Javelin Pharmaceuticals, Inc (JAV) Research report for Javelin Pharmaceuticals, Inc (JAV) Research report for Javelin Pharmaceuticals, Inc (JAV) Research report for Javelin Pharmaceuticals, Inc (JAV)
   

News for Javelin Pharmaceuticals, Inc (JAV)

Markets
Quote
Depth/LII
Options
Charts
News
Company
Financials
Insiders
Filings
Analyst
Earnings
Historical
News ·  Blogs ·  Filings
Symbol:  | Recent Quotes powered by
  quotemedia.com
News for Javelin Pharmaceuticals Inc  (JAV) 
|
$ 1.17   0.02 (+1.74%) Volume: 369.28 k 4:00 PM EST Feb 9, 2010
After Hours:  $ 1.17 0.00 (0.00%) Volume: 1.76 k 4:34 PM EST Feb 9, 2010
Wed, Feb 03, 2010
9:02 AM Myriad Pharmaceuticals to Present at BIO CEO & Investor Conference on February 8th - GlobeNewswire
Tue, Feb 02, 2010
9:10 AM FDA Accepts Javelin Pharmaceuticals' Submission and Files New Drug Application for Dyloject(TM) - GlobeNewswire
8:55 AM FDA Accepts Javelin Pharmaceuticals' Dyloject(TM) New Drug Application for Formal Review - Business Wire
Tue, Dec 22, 2009
1:35 PM Finkelstein Thompson LLP Announces Investigation of Javelin Pharmaceuticals, Inc. - Business Wire
Mon, Dec 21, 2009
11:54 AM Levi & Korsinsky, LLP Investigates Possible Breach of Fiduciary Duty by the Board of Javelin Pharmaceuticals, Inc. - JAV - Business Wire
Fri, Dec 18, 2009
8:15 AM Myriad Pharmaceuticals to Acquire Javelin Pharmaceuticals - GlobeNewswire
Wed, Dec 02, 2009
9:23 AM Javelin Pharmaceuticals Submits Dyloject(TM) New Drug Application to FDA for Management of Acute Moderate-to-Severe Pain in Adults - Business Wire
Tue, Nov 10, 2009
7:00 AM Javelin Pharmaceuticals, Inc. Reports Third Quarter 2009 Results - Business Wire
Wed, Nov 04, 2009
9:15 AM Javelin Pharmaceuticals to Announce Third Quarter 2009 Financial Results - Business Wire
Fri, Oct 30, 2009
9:25 AM Javelin Pharmaceuticals, Inc. Tops Up Balance Sheet Through Registered Direct Offering - Business Wire
Thu, Dec 04, 2008
9:33 AM NASDAQ OMX and Leerink Swann to Co-Host HealthCare Industry Forum - GlobeNewswire
Mon, Jan 22, 2007
9:00 AM American Stock Exchange to Host First Annual Healthcare Conference in Boston on February 8, 2007 - PR Newswire
Wed, Oct 25, 2006
7:45 AM Frost & Sullivan Names Javelin Pharmaceuticals Entrepreneurial Company of the Year for Intranasal Therapeutics - PR Newswire
Thu, Jul 20, 2006
9:57 AM American Stock Exchange Lists Common Stock of Javelin Pharmaceuticals, Inc. - PR Newswire
Thu, Jul 13, 2006
8:01 AM Javelin Pharmaceuticals, Inc. Receives Approval for Listing on the American Stock Exchange - PR Newswire
Fri, Jul 07, 2006
8:05 AM Javelin Pharmaceuticals Wins Phase II SBIR Grant - PR Newswire
Thu, Jul 06, 2006
11:26 AM Javelin Pharmaceuticals CEO to Present at Leerink Swann's Emerging Technologies in Pain Medicine Roundtable and Conference - PR Newswire
Wed, Jun 21, 2006
8:05 AM Mark Matthews Joins Javelin Pharmaceuticals as VP of Commercial Affairs - PR Newswire
Thu, Jun 15, 2006
8:30 AM Javelin Elects Martin Driscoll and Neil Flanzraich to Board - PR Newswire
Wed, May 31, 2006
11:42 AM Javelin Enrolls First Patient In Pivotal Phase III Postop Pain Study of Dyloject(TM) - PR Newswire
Wed, May 24, 2006
8:05 AM Javelin Pharmaceuticals' CEO to Present at Friedman, Billings, Ramsey's 2006 Growth Investor Conference - PR Newswire
Tue, May 23, 2006
8:05 AM Javelin Enrolls First Patient in Pivotal Phase III Study of Rylomine(TM) - PR Newswire
Mon, May 22, 2006
8:30 AM Javelin Pharmaceuticals' VP to Give Plenary Lecture at 2nd Annual Specialty Pharma Global Summit - PR Newswire
5:37 AM LaVoie Strategic Communications Group, Inc. Adds Three New Life Science Clients to Growing Roster - PR Newswire
Mon, May 15, 2006
1:01 PM GE Introduces New Series of Laptop-Size Ultrasound Systems to Expand Ultrasound's Role in Healthcare - US Equity News
  Page 1 of 2   Next Page

   
 
Home > Companies > Javelin Pharmaceuticals, Inc